Cargando…

Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro

Purpose: To determine the effect of Bu-Shen-Zhu-Yun Decoction (BSZY-D) on the kisspeptin through JAK2/STAT5 signaling pathway in hyperprolactinemia (HPRL) infertility. Method: SD rats were treated with BSZY-D for cerebrospinal fluid (CSF) extraction. GT1-7 cells were subjected to different treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Hua, Zhou, Huifang, Lu, Jianxia, Zhang, Qing, Tang, Xingran, Shang, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436908/
https://www.ncbi.nlm.nih.gov/pubmed/34424219
http://dx.doi.org/10.18632/aging.203426
_version_ 1783752071926775808
author Feng, Hua
Zhou, Huifang
Lu, Jianxia
Zhang, Qing
Tang, Xingran
Shang, Yujie
author_facet Feng, Hua
Zhou, Huifang
Lu, Jianxia
Zhang, Qing
Tang, Xingran
Shang, Yujie
author_sort Feng, Hua
collection PubMed
description Purpose: To determine the effect of Bu-Shen-Zhu-Yun Decoction (BSZY-D) on the kisspeptin through JAK2/STAT5 signaling pathway in hyperprolactinemia (HPRL) infertility. Method: SD rats were treated with BSZY-D for cerebrospinal fluid (CSF) extraction. GT1-7 cells were subjected to different treatments. The phosphorylation levels of JAK2 and STAT5, and the expressions of PRLR and kisspeptin of GT1-7 cells in different groups were detected by western blot, RT-qPCR and immunofluorescence. The expressions of CSN5 and GATA1 and other molecular features were checked by western blot, RT-PCR, co-immunoprecipitation and renilla luciferase activity. Results: The phosphorylation levels of JAK2 and STAT5, and the expressions of PRLR and kisspeptin in the HPRL group were significantly decreased, and these changes could be reversed after BSZY-D treatment. In addition, the presence of PRLR deubiquitination was detected in the HPRL group, which could be reversed by shRNA-CSN5, suggesting that BSZY-D played a role through targeting CSN5. The binding level of GATA1 and CSN5 promoter in the HPRL group was significantly decreased, but elevated in the HPRL (BSZY-D/CSF) group (P < 0.05). Conclusion: BSZY-D improved the transcription activity of GATA1 and increased the binding of GATA1 and CSN5. BSZY-D was involved in the deubiquitination of PRLR, which contributes to alleviating the symptoms of HPRL infertility.
format Online
Article
Text
id pubmed-8436908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-84369082021-09-14 Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro Feng, Hua Zhou, Huifang Lu, Jianxia Zhang, Qing Tang, Xingran Shang, Yujie Aging (Albany NY) Research Paper Purpose: To determine the effect of Bu-Shen-Zhu-Yun Decoction (BSZY-D) on the kisspeptin through JAK2/STAT5 signaling pathway in hyperprolactinemia (HPRL) infertility. Method: SD rats were treated with BSZY-D for cerebrospinal fluid (CSF) extraction. GT1-7 cells were subjected to different treatments. The phosphorylation levels of JAK2 and STAT5, and the expressions of PRLR and kisspeptin of GT1-7 cells in different groups were detected by western blot, RT-qPCR and immunofluorescence. The expressions of CSN5 and GATA1 and other molecular features were checked by western blot, RT-PCR, co-immunoprecipitation and renilla luciferase activity. Results: The phosphorylation levels of JAK2 and STAT5, and the expressions of PRLR and kisspeptin in the HPRL group were significantly decreased, and these changes could be reversed after BSZY-D treatment. In addition, the presence of PRLR deubiquitination was detected in the HPRL group, which could be reversed by shRNA-CSN5, suggesting that BSZY-D played a role through targeting CSN5. The binding level of GATA1 and CSN5 promoter in the HPRL group was significantly decreased, but elevated in the HPRL (BSZY-D/CSF) group (P < 0.05). Conclusion: BSZY-D improved the transcription activity of GATA1 and increased the binding of GATA1 and CSN5. BSZY-D was involved in the deubiquitination of PRLR, which contributes to alleviating the symptoms of HPRL infertility. Impact Journals 2021-08-23 /pmc/articles/PMC8436908/ /pubmed/34424219 http://dx.doi.org/10.18632/aging.203426 Text en Copyright: © 2021 Feng et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Feng, Hua
Zhou, Huifang
Lu, Jianxia
Zhang, Qing
Tang, Xingran
Shang, Yujie
Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title_full Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title_fullStr Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title_full_unstemmed Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title_short Bu-Shen-Zhu-Yun decoction induces PRLR deubiquitination and JAK2/STAT5 activation via CSN5 in vitro
title_sort bu-shen-zhu-yun decoction induces prlr deubiquitination and jak2/stat5 activation via csn5 in vitro
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436908/
https://www.ncbi.nlm.nih.gov/pubmed/34424219
http://dx.doi.org/10.18632/aging.203426
work_keys_str_mv AT fenghua bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro
AT zhouhuifang bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro
AT lujianxia bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro
AT zhangqing bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro
AT tangxingran bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro
AT shangyujie bushenzhuyundecoctioninducesprlrdeubiquitinationandjak2stat5activationviacsn5invitro